SCHEMBL5683759

SCHEMBL5683759

NC1C[CH]C(=O)CC1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14524980 0.69
SCHEMBL14348202 0.69
SCHEMBL3310184 0.60
SCHEMBL3900672 0.60
SCHEMBL3899974 0.60
SCHEMBL11648439 0.60
SCHEMBL11648443 0.60
SCHEMBL11648445 0.60
SCHEMBL10724168 0.58
SCHEMBL3996873 0.57 ANPEP (0.68)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1620381-A1 HYDROANTHRACENE BASED COMPOUNDS AS ANTICANCER AGENTS Dabur Research Foundation (IN) 2006-02-01 EP claimed
US-6949557-B2 Hydroanthracene based compounds as anticancer agents DABUR RESEARCH FOUNDATION (IN) 2005-09-27 US claimed
WO-2004096742-A1 HYDROANTHRACENE BASED COMPOUNDS AS ANTICANCER AGENTS DABUR RESEARCH FOUNDATION (IN) 2004-11-11 WO claimed
US-20040220197-A1 Hydroanthracene based compounds as anticancer agents DABUR RESEARCH FOUNDATION 2004-11-04 US claimed
EP-1620381-A1 HYDROANTHRACENE BASED COMPOUNDS AS ANTICANCER AGENTS Dabur Research Foundation (IN) 2006-02-01 EP disclosed
US-6949557-B2 Hydroanthracene based compounds as anticancer agents DABUR RESEARCH FOUNDATION (IN) 2005-09-27 US disclosed
WO-2004096742-A1 HYDROANTHRACENE BASED COMPOUNDS AS ANTICANCER AGENTS DABUR RESEARCH FOUNDATION (IN) 2004-11-11 WO disclosed
US-20040220197-A1 Hydroanthracene based compounds as anticancer agents DABUR RESEARCH FOUNDATION 2004-11-04 US disclosed